Vimarsana
Biggest News Aggregation in the World

Page 10 - B Pfizer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from B Pfizer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In B Pfizer Today - Breaking & Trending Today

FDA authorizes Pfizer COVID-19 pill for emergency use - Vimarsana News

FDA authorizes Pfizer COVID-19 pill for emergency use

The Food and Drug Administration on Wednesday authorized for emergency use a pill from drugmaker Pfizer that staved off hospitalization and death from COVID-19 in clinical trials, adding a major tool to the U.S. effort against the virus.

FDA authorizes Pfizer COVID-19 pill for emergency use - Vimarsana News

FDA authorizes Pfizer COVID-19 pill for emergency use

The Food and Drug Administration on Wednesday authorized for emergency use a pill from drugmaker Pfizer that staved off hospitalization and death from COVID-19 in clinical trials, adding a major weapon to the U.S. arsenal against the virus.

CDC panel: mRNA vaccines 'preferred' over J&J shot, citing blood clotting - Vimarsana News

CDC panel: mRNA vaccines 'preferred' over J&J shot, citing blood clotting

COVID-19 vaccines that use messenger RNA are preferable to the Johnson & Johnson vaccine, advisers to the Centers for Disease Control and Prevention said Thursday after reviewing data on an extremely rare but serious blood-clotting disorder linked to the J&J shot.

CDC panel: mRNA vaccines 'preferred' over J&J shot, citing blood clotting - Vimarsana News

CDC panel: mRNA vaccines 'preferred' over J&J shot, citing blood clotting

COVID-19 vaccines that use messenger RNA are preferable to the Johnson & Johnson vaccine, advisers to the Centers for Disease Control and Prevention said Thursday after reviewing data on an extremely rare but serious blood-clotting disorder linked to the J&J shot.

Pfizer jabs protect 70% against hospitalization from omicron - Vimarsana News

Pfizer jabs protect 70% against hospitalization from omicron

A two-dose Pfizer/BioNTech vaccination provides just 33% protection against infection by the omicron variant of the coronavirus, but 70% protection against hospitalization, according to a large-scale analysis in South Africa released Tuesday.